174 related articles for article (PubMed ID: 19858421)
1. Letter by Choi et al regarding article, "Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the raloxifene use for the heart trial: results of subgroup analyses by age and other factors".
Choi BG; Vilahur G; Badimon JJ
Circulation; 2009 Oct; 120(17):e147; author reply e148. PubMed ID: 19858421
[No Abstract] [Full Text] [Related]
2. Can estrogen or selective estrogen-receptor modulators preserve cognitive function in elderly women?
Mayeux R
N Engl J Med; 2001 Apr; 344(16):1242-4. PubMed ID: 11309641
[No Abstract] [Full Text] [Related]
3. [Additional effect of SERM: central nervous system].
Honjo H
Clin Calcium; 2004 Oct; 14(10):69-72. PubMed ID: 15577134
[TBL] [Abstract][Full Text] [Related]
4. [Cardiovascular effects of selective estrogen receptor modulators. Current perspectives].
Simoncini T; Mannella P; Genazzani AR
Recenti Prog Med; 2003 Feb; 94(2):51-6. PubMed ID: 12908369
[TBL] [Abstract][Full Text] [Related]
5. Raloxifene for prevention of osteoporotic fractures.
Diehr S; Mijal S; Nashelsky J
Am Fam Physician; 2005 Jul; 72(1):132-4. PubMed ID: 16035693
[No Abstract] [Full Text] [Related]
6. [Selective estrogen receptor modulator].
Ohta H
Clin Calcium; 2004 Jan; 14(1):165-72. PubMed ID: 15576973
[TBL] [Abstract][Full Text] [Related]
7. Raloxifene: another selective estrogen modulator.
Kellen JA
In Vivo; 2001; 15(6):459-60. PubMed ID: 11887329
[TBL] [Abstract][Full Text] [Related]
8. Effect of HMR 3339, a novel selective estrogen receptor modulator, on C-reactive protein levels in healthy postmenopausal women.
Vogelvang TE; Mijatovic V; Kenemans P; Schalkwijk CG; van der Mooren MJ
Am J Cardiol; 2004 Nov; 94(9):1205-8. PubMed ID: 15518626
[TBL] [Abstract][Full Text] [Related]
9. Effects of hormone replacement therapy or raloxifene on ambulatory blood pressure and arterial stiffness in treated hypertensive postmenopausal women.
da Costa LS; de Oliveira MA; Rubim VS; Wajngarten M; Aldrighi JM; Rosano GM; Neto CD; Gebara OC
Am J Cardiol; 2004 Dec; 94(11):1453-6. PubMed ID: 15566926
[TBL] [Abstract][Full Text] [Related]
10. On looking at subgroups.
Wittes J
Circulation; 2009 Feb; 119(7):912-5. PubMed ID: 19237669
[No Abstract] [Full Text] [Related]
11. XbaI polymorphism of the estrogen receptor alpha gene influences the effect of raloxifene on the endothelial function.
Zavratnik A; Zegura B; Marc J; Prezelj J; Pfeifer M
Maturitas; 2010 Sep; 67(1):84-90. PubMed ID: 20609538
[TBL] [Abstract][Full Text] [Related]
12. Lessons from RUTH.
Pines A
Climacteric; 2006 Oct; 9(5):323-4. PubMed ID: 17000580
[TBL] [Abstract][Full Text] [Related]
13. The science of selective estrogen receptor modulators: concept to clinical practice.
Jordan VC
Clin Cancer Res; 2006 Sep; 12(17):5010-3. PubMed ID: 16951214
[No Abstract] [Full Text] [Related]
14. Five female cases of prolonged depression in chronic anorexia nervosa treated with selective estrogen receptor modulator raloxifene-augmented therapy.
Yokoyama S; Sugiyama N; Sugiyama E; Amano N
J Clin Psychopharmacol; 2008 Dec; 28(6):721-2. PubMed ID: 19011455
[No Abstract] [Full Text] [Related]
15. Selective estrogen receptor modulators: raloxifene.
Rogowski A; Fidler B
Med Health R I; 1999 Jan; 82(1):29-30. PubMed ID: 15600142
[No Abstract] [Full Text] [Related]
16. Risk-benefit profiles of raloxifene for women.
Stefanick ML
N Engl J Med; 2006 Jul; 355(2):190-2. PubMed ID: 16837684
[No Abstract] [Full Text] [Related]
17. The STAR trial: evidence for raloxifene as a breast cancer risk reduction agent for postmenopausal women.
Bevers TB
J Natl Compr Canc Netw; 2007 Sep; 5(8):719-24. PubMed ID: 17927929
[TBL] [Abstract][Full Text] [Related]
18. Vascular effects of raloxifene in post-menopausal women.
Rebecchi I; Ceresini G; Marchini L; Morganti S; Denti L; Bacchi-Modena A; Sgarabotto M; Baldini M; Ablondi F; Bertone L; Montanari I; Ceda GP; Valenti G
J Endocrinol Invest; 2002; 25(10 Suppl):93-4. PubMed ID: 12508934
[No Abstract] [Full Text] [Related]
19. The effect of raloxifene on cognitive function in postmenopausal women: a randomized clinical trial.
Haskell SG; Richardson ED
Conn Med; 2004; 68(6):355-8. PubMed ID: 15266884
[TBL] [Abstract][Full Text] [Related]
20. Are the serum levels of sCD40L modified by raloxifene in postmenopausal women?
Oviedo PJ; Hermenegildo C; Novella S; Tarín JJ; Cano A
Eur J Obstet Gynecol Reprod Biol; 2008 Oct; 140(2):296-7. PubMed ID: 18583017
[No Abstract] [Full Text] [Related]
[Next] [New Search]
